These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28125239)

  • 41. Materials engineering of solid-state dosage forms.
    Li T
    Pharm Res; 2008 Apr; 25(4):949-51; discussion 951-2. PubMed ID: 17985215
    [No Abstract]   [Full Text] [Related]  

  • 42. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.
    Baghel S; Cathcart H; O'Reilly NJ
    J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Theme issue "Solid state and solid dosage forms".
    Kleinebudde P
    Eur J Pharm Biopharm; 2009 Jan; 71(1):1. PubMed ID: 18817869
    [No Abstract]   [Full Text] [Related]  

  • 44. A new design for the review and appraisal of semi-solid dosage forms: Semi-solid Control Diagram (SSCD).
    Nardi-Ricart A; Linares MJ; Villca-Pozo F; Pérez-Lozano P; Suñé-Negre JM; Bachs-deMiquel L; Roig-Carreras M; Suñé-Pou M; Nofrerias-Roig I; García-Montoya E
    PLoS One; 2018; 13(9):e0201643. PubMed ID: 30192759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations.
    Paudel A; Worku ZA; Meeus J; Guns S; Van den Mooter G
    Int J Pharm; 2013 Aug; 453(1):253-84. PubMed ID: 22820134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Achieving polymorph selectivity in the crystallization of pharmaceutical solids: basic considerations and recent advances.
    Reutzel-Edens SM
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):806-15. PubMed ID: 17117688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation.
    Patil H; Tiwari RV; Repka MA
    AAPS PharmSciTech; 2016 Feb; 17(1):20-42. PubMed ID: 26159653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Applications of process analytical technology to crystallization processes.
    Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS
    Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
    Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
    J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mid-Infrared Spectroscopy of Pharmaceutical Solids.
    Brittain HG
    Profiles Drug Subst Excip Relat Methodol; 2018; 43():321-358. PubMed ID: 29678263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study of pharmaceutical solid dispersions by microthermal analysis.
    Galop M
    Pharm Res; 2005 Feb; 22(2):293-302. PubMed ID: 15783078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Process analytical applications of Raman spectroscopy.
    Rantanen J
    J Pharm Pharmacol; 2007 Feb; 59(2):171-7. PubMed ID: 17270071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
    Vo CL; Park C; Lee BJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):799-813. PubMed ID: 24056053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Applications of solid-state NMR to pharmaceutical polymorphism and related matters.
    Harris RK
    J Pharm Pharmacol; 2007 Feb; 59(2):225-39. PubMed ID: 17270076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hot-melt extrusion.
    Jana S; Miloslava R
    Ceska Slov Farm; 2012 Jun; 61(3):87-92. PubMed ID: 22913823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymorph characterization of active pharmaceutical ingredients (APIs) using low-frequency Raman spectroscopy.
    Larkin PJ; Dabros M; Sarsfield B; Chan E; Carriere JT; Smith BC
    Appl Spectrosc; 2014; 68(7):758-76. PubMed ID: 25014842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of molecular interactions in solid dosage forms; challenge to molecular pharmaceutics.
    Yamamoto K; Limwikrant W; Moribe K
    Chem Pharm Bull (Tokyo); 2011; 59(2):147-54. PubMed ID: 21297291
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In-line solid state prediction during pharmaceutical hot-melt extrusion in a 12 mm twin screw extruder using Raman spectroscopy.
    Saerens L; Ghanam D; Raemdonck C; Francois K; Manz J; Krüger R; Krüger S; Vervaet C; Remon JP; De Beer T
    Eur J Pharm Biopharm; 2014 Aug; 87(3):606-15. PubMed ID: 24657540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lean Raman imaging for rapid assessment of homogeneity in pharmaceutical formulations.
    Brown SC; Claybourn M; Sievwright D; Fearnside V; Ashman C
    Appl Spectrosc; 2010 Apr; 64(4):442-7. PubMed ID: 20412630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.